Variable downcanyon morphology controlling the recent activity of shelf-incised submarine canyons (Alboran Sea, western Mediterranean)GEOMORPHOLOGYIF3.32024-05-015OAAI
Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian PatientsPHARMACEUTICSIF5.52022-04-0710OAAI
Population pharmacokinetics of phenobarbital in Caucasian patients with epilepsyEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72020-10-012PREAI
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulationSCIENTIFIC REPORTSIF3.92020-03-1315OAAI
Same meat, different gravy: ignore the new names of mycobacteriaEUROPEAN RESPIRATORY JOURNALIF212019-07-1150OAAI
Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphomaBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32016-09-0630OAAI
Do We Have Strategies to Improve the Preventive Treatment of Latent Tuberculosis Infection?CLINICAL INFECTIOUS DISEASESIF7.32016-03-063OAAI
Population Pharmacokinetic/Pharmacogenetic Model for Optimization of Efavirenz Therapy in Caucasian HIV-Infected PatientsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52011-11-0151OAAI
Influence of the Cytochrome P450 2B6 Genotype on Population Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus PatientsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52009-07-0168OAAI
Efavirenz-rifampicin interaction: therapeutic drug monitoring to efavirenz dosage optimization in HIV/TBC patientsAIDSIF3.12008-11-3013OAAI
COST SAVINGS OF CORONARY CT ANGIOGRAPHY VS. CARDIAC CATHETERIZATION TO EVALUATE PATIENTS WITH AN ABNORMAL OR NONDIAGNOSTIC STRESS TESTVALUE IN HEALTHIF62008-11-010OAAI
Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions伊曲康唑的治疗药物监测和药代动力学相互作用的相关性CLINICAL MICROBIOLOGY AND INFECTIONIF8.52006-12-0128OAAI